Hassan Fahmi Selected Research

Hassan Fahmi Research Topics

Disease

31	Osteoarthritis 01/2022 - 02/2002
18	Inflammation (Inflammations) 07/2021 - 12/2003
6	Arthritis (Polyarthritis) 12/2019 - 01/2002
6	Fibrosis (Cirrhosis) 12/2017 - 01/2011
5	Rheumatoid Arthritis 04/2013 - 12/2003
2	Necrosis 01/2011 - 01/2006
1	Obesity 01/2022
1	Knee Osteoarthritis 01/2020
1	Bone Resorption 12/2019
1	Lung Injury 12/2017
1	Hypoxia (Hypoxemia) 04/2013
1	Sclerosis 11/2012
1	Heart Diseases (Heart Disease) 10/2012
1	Body Weight (Weight, Body) 05/2012
1	Hypertrophy 05/2012
1	Experimental Arthritis 02/2011
1	Systemic Scleroderma (Systemic Sclerosis) 01/2011
1	Disease Progression 01/2007

Drug/Important Bio-Agent (IBA)

6	PPAR gammaIBA 04/2013 - 01/2002
5	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 07/2021 - 02/2002
5	Dinoprostone (PGE2)FDA Link 05/2014 - 12/2003
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2011
4	EnzymesIBA 12/2019 - 09/2004
4	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 08/2017 - 01/2010
4	ProstaglandinsIBA 01/2017 - 09/2004
3	Prostaglandin D2IBA 12/2020 - 01/2017
3	LipocalinsIBA 12/2020 - 06/2013
3	prostaglandin R2 D-isomerase (prostaglandin D2 synthase)IBA 12/2020 - 06/2013
3	Ephrin-B2 (Ephrin B2)IBA 12/2017 - 03/2016
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 06/2013 - 02/2002
3	LigandsIBA 02/2011 - 01/2002
2	CytokinesIBA 07/2021 - 01/2011
2	Interleukin-6 (Interleukin 6)IBA 07/2021 - 01/2006
2	Complement Factor D (Factor D)IBA 01/2020 - 10/2018
2	Cathepsin KIBA 12/2019 - 02/2013
2	resolvin D1IBA 12/2019 - 08/2016
2	CollagenIBA 12/2019 - 01/2011
2	DisintegrinsIBA 12/2017 - 04/2013
2	Metalloproteases (Metalloproteinases)IBA 12/2017 - 04/2013
2	Ramipril (Altace)FDA LinkGeneric 04/2013 - 10/2012
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 04/2013 - 01/2011
2	Pharmaceutical PreparationsIBA 10/2012 - 02/2002
2	Glucosamine (Dona)IBA 03/2012 - 01/2007
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2009 - 01/2006
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2005 - 12/2003
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Interleukin-8 (Interleukin 8)IBA 07/2021
1	AdipokinesIBA 01/2020
1	Biological ProductsIBA 12/2019
1	Therapeutic UsesIBA 12/2019
1	Durapatite (Hydroxylapatite)IBA 12/2019
1	prostaglandin D2 receptorIBA 01/2017
1	ProtandimIBA 01/2017
1	gingerolIBA 01/2017
1	ImmunosorbentsIBA 08/2016
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 08/2016
1	pentosidineIBA 09/2014
1	CarnosineIBA 09/2014
1	AldehydesIBA 09/2014
1	Hyaluronic Acid (Hyaluronan)IBA 08/2014
1	Sorbitol (Yal)FDA Link 08/2014
1	Prostaglandin-E SynthasesIBA 05/2014
1	Collagen Type II (Type II Collagen)IBA 04/2013
1	Aggrecans (Aggrecan)IBA 04/2013
1	Syndecan-4IBA 04/2013
1	Matrix Metalloproteinase 13IBA 04/2013
1	ThrombospondinsIBA 04/2013
1	Matrix Metalloproteinases (MMPs)IBA 04/2013
1	Peptide Hydrolases (Proteases)FDA Link 02/2013
1	strontium ranelate (protelos)IBA 02/2013
1	StrontiumIBA 02/2013
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2013
1	EphB4 ReceptorIBA 11/2012
1	Tartrate-Resistant Acid PhosphataseIBA 11/2012
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2012
1	Type 1 Angiotensin ReceptorIBA 10/2012
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2012
1	Platelet Endothelial Cell Adhesion Molecule-1IBA 05/2012
1	Collagen Type XIBA 05/2012
1	CalciumIBA 05/2012
1	Bromodeoxyuridine (BrdU)IBA 05/2012
1	thymoquinoneIBA 01/2011
1	indium-bleomycinIBA 01/2011
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2011
1	Interleukin-1beta (Interleukin 1 beta)IBA 01/2011
1	PPAR-gamma AgonistsIBA 07/2007
1	Pioglitazone (Actos)FDA Link 07/2007
1	ChondroitinIBA 01/2007
1	Interleukin-1 (Interleukin 1)IBA 01/2007
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2006
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 02/2006
1	Transcription Factors (Transcription Factor)IBA 05/2004
1	nimesulide (Aulin)IBA 02/2002

Therapy/Procedure

2	Therapeutics 01/2020 - 11/2019
1	Oral Administration 10/2012